Asclemed Lidolog Kit lidocaine injection recalled for barcode labeling defect
Asclemed USA Inc. is recalling Lidolog Kit, which contains lidocaine injection, because the label wrap covers the barcode, making it difficult to scan. This labeling defect affects 18 kits distributed in Tennessee.
From the FDA notice · Read the official notice ↗
What to do
- Check your inventory for Lidolog Kit lot 070126X1 with expiration 12/31/2027.
- Do not use affected kits if the barcode cannot be scanned clearly.
- Contact your supplier or Asclemed USA Inc. for return or replacement instructions.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
- Sold in
- Within U.S. - Tennessee
- Made for
- Adults (0 months and older)
Details
- Units affected
- 18 kits
- Illnesses reported
- None reported
- Manufactured in
- 379 Van Ness Ave Ste 1403, N/A, Torrance, CA, United States
- Classification
- Class III
- Recall number
- D-0713-2026
In the FDA's words
- Description
- Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01. Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan Lot: 070126X1, Exp. 12/31/2027. Distribution: Within U.S. - Tennessee Affected quantity: 18 kits
- Hazard
- Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan